Skip to main content
OpenTrials

Clinical trial condition

Relapsed or Refractory Hodgkin Lymphoma

Explore clinical trials studying Relapsed or Refractory Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Relapsed or Refractory Hodgkin Lymphoma trial results

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • City of Hope Cancer Center (Data Collection Only) Duarte, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • University of Miami Miami, Florida, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
Locations
  • CH de la Côte Basque, service Hématologie Clinique Bayonne, France
  • CHU de Bordeaux, service Hématologie Clinique et Thérapie cellulaire Bordeaux, France
  • CHU de Caen, service Hématologie Clinique Caen, France
  • Institut Paoli Calmettes, service Hématologie Clinique Marseille, France
Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
Locations
  • Aurora, Colorado, United States
  • Kansas City, Missouri, United States
  • New York, United States
  • Houston, Texas, United States
View all 18 locations
Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations
  • Busan University Hospital Busan, South Korea
  • Dong-A University Busan, South Korea
  • Kosin University Gospel Hospital Busan, South Korea
  • Asan Medical Center Seoul, South Korea